Vascular disrupting agent for neovascular age related macular degeneration: a pilot study of the safety and efficacy of intravenous combretastatin a-4 phosphate

BACKGROUND: This study was designed to assess the safety, tolerability, and efficacy of intravenous infusion of CA4P in patients with neovascular age-related macular degeneration (AMD). METHODS: Prospective, interventional, dose-escalation clinical trial. Eight patients with neovascular AMD refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Mohamed A, Do, Diana V, Sepah, Yasir J, Shah, Syed M, Van Anden, Elizabeth, Hafiz, Gulnar, Donahue, J Kevin, Rivers, Richard, Balkissoon, Jai, Handa, James T, Campochiaro, Peter A, Nguyen, Quan Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552984/
https://www.ncbi.nlm.nih.gov/pubmed/23316779
http://dx.doi.org/10.1186/2050-6511-14-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552984/
https://www.ncbi.nlm.nih.gov/pubmed/23316779
http://dx.doi.org/10.1186/2050-6511-14-7

Ejemplares similares